SEC Form 4/A · accession 0000908662-18-000175
XERIS PHARMACEUTICALS INC · XERS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owners
Palmetto Partners, Ltd.
10% Owner
Palmetto Partners 2014, LP
10% Owner
Palmetto Partners 2015, LP
10% Owner
Period of report
Jun 25, 2018
Accepted (ET)
Jun 28, 2018 · 8:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001346302
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred StockF1,F5,F2 | — | Jun 25, 2018 | C | 1,657,125 | D | — | — | Common Stock | 930,383 | 0 | D |
| Series C Preferred StockF3,F5,F2 | — | Jun 25, 2018 | C | 1,036,599 | D | — | — | Common Stock | 581,992 | 0 | D |
| Series C Preferred StockF4,F5,F2 | — | Jun 25, 2018 | C | 797,384 | D | — | — | Common Stock | 447,686 | 0 | D |
Explanation of responses
- F1The securities are owned by Palmetto Partners 2014, LP, who is a member of a group with Palmetto Partners, Ltd. and Palmetto Partners 2015, LP.
- F2Each share of Preferred Stock automatically converted into Common Stock, for no additional payment or consideration, on a 1.78112-for-1 basis, at the closing of the Issuer's initial public offering on June 25, 2018 and had no expiration date.
- F3The securities are owned by Palmetto Partners 2015, LP, who is a member of a group with Palmetto Partners, Ltd. and Palmetto Partners 2014, LP.
- F4The securities are owned by Palmetto Partners, Ltd., who is a member of a group with Palmetto Partners 2014, LP and Palmetto Partners 2015, LP.
- F5This Form 4/A is being filed to correct the title of the derivative securities held by the Reporting Persons.